(Q41067185)

26 September 2017

N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor (English)

1 reference

26 September 2017

0 references

0 references

Soderstrom K

1

1 reference

26 September 2017

Choi H

2

1 reference

26 September 2017

Berman FW

3

1 reference

26 September 2017

Aldrich JV

4

1 reference

26 September 2017

Murray TF

5

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

European Journal of Pharmacology

26 September 2017

1 reference

26 September 2017

338

1 reference

26 September 2017

2

1 reference

26 September 2017

191-197

1 reference

Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Characterization and distribution of a cloned rat mu-opioid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Specific receptor for the opioid peptide dynorphin: structure--activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

D-PRO10dynorphin-(1–11) is a highly potent and selective ligand for ϰ opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Opioid Agonist-Antagonist Drugs in Acute and Chronic Pain States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Structure-activity relationship of N17'-substituted norbinaltorphimine congeners. Role of the N17' basic group in the interaction with a putative address subsite on the kappa opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

Comparison of kappa 2-opioid receptors in guinea pig brain and guinea pig ileum membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981948-6

10.1016/S0014-2999(97)81948-6

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference